Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer.

Wills C, Watts K, Maughan TS, Fisher D, Al-Tassan NA, Houlston RS, Escott-Price V, Cheadle JP

Open source

DOI
10.1002/gcc.23133
Published
2023 Jun
Container
Genes, chromosomes & cancer
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/gcc.23133,
  title = {Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer.},
  author = {Wills C and Watts K and Maughan TS and Fisher D and Al-Tassan NA and Houlston RS and Escott-Price V and Cheadle JP},
  year = {2023},
  journal = {Genes, chromosomes \& cancer},
  doi = {10.1002/gcc.23133},
  url = {https://doi.org/10.1002/gcc.23133}
}

RIS

TY  - JOUR
TI  - Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer.
AU  - Wills C
AU  - Watts K
AU  - Maughan TS
AU  - Fisher D
AU  - Al-Tassan NA
AU  - Houlston RS
AU  - Escott-Price V
AU  - Cheadle JP
PY  - 2023
JO  - Genes, chromosomes & cancer
DO  - 10.1002/gcc.23133
UR  - https://doi.org/10.1002/gcc.23133
ER  - 

APA

C, W., K, W., TS, M., D, F., NA, A., RS, H., V, E., & JP, C. (2023). Germline variation in RASAL2 may predict survival in patients with RAS-activated colorectal cancer.. Genes, chromosomes & cancer. https://doi.org/10.1002/gcc.23133

Source records